Advertisement
Advertisement
INO
Inovio Pharmaceuticals, Inc.
0.67
USDSponsored
-0.01
-0.86%
Aug 07, 15:59 UTC -4
Closed
After-Market
0.66
-0.01
-0.90%
INO Earnings Reports
Positive Surprise Ratio
INO beat 20 of 42 last estimates.
48%
Next Report
Next Week
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.21
Implied change from Q1 26 (Revenue/ EPS)
--
/-25.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/-65.57%
Inovio Pharmaceuticals, Inc. earnings per share and revenue
On May 13, 2026, INO reported earnings of -0.28 USD per share (EPS) for Q1 26, beating the estimate of -0.35 USD, resulting in a 20.79% surprise. Revenue reached --, compared to an expected 252.50 thousand, with a -100.00% difference. The market reacted with a +1.49% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.21 USD, with revenue projected to reach -- USD, implying an decrease of -25.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
Zymeworks Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.62
Surprise
-32.31%
Intellia Therapeutics, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.81
Actual
-$0.80
Surprise
+1.86%
CytomX Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-13.78%
X4 Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Arcturus Therapeutics Holdings Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.01
Actual
-$0.84
Surprise
+17.53%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
Xenon Pharmaceuticals Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.16
Actual
-$1.11
Surprise
+4.36%
Edgewise Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.53
Surprise
-10.55%
Zai Lab Limited - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.06
Actual
-$0.46
Surprise
-599.09%
FAQ
What were Inovio Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Inovio Pharmaceuticals, Inc. reported EPS of -$0.28, beating estimates by 20.79%, and revenue of $0.00, -100% below expectations.
How did the market react to Inovio Pharmaceuticals, Inc.'s Q1 2026 earnings?
The stock price moved up 1.49%, changed from $1.34 before the earnings release to $1.36 the day after.
When is Inovio Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Inovio Pharmaceuticals, Inc.'s next earnings report?
Based on 4
analysts, Inovio Pharmaceuticals, Inc. is expected to report EPS of -$0.21 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement